Akynzeo Interactions
There are 558 drugs known to interact with Akynzeo (netupitant/palonosetron), along with 6 disease interactions. Of the total drug interactions, 186 are major, 343 are moderate, and 29 are minor.
- View all 558 medications that may interact with Akynzeo
- View Akynzeo disease interactions (6)
Most frequently checked interactions
View interaction reports for Akynzeo (netupitant / palonosetron) and the medicines listed below.
- Aimovig (erenumab)
- biotin
- carboplatin
- Celebrex (celecoxib)
- Corlanor (ivabradine)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- dacarbazine
- Decadron (dexamethasone)
- dexamethasone
- duloxetine
- Effexor XR (venlafaxine)
- famotidine
- Forteo (teriparatide)
- gabapentin
- granisetron
- Hizentra (immune globulin subcutaneous)
- hydromorphone
- Imitrex (sumatriptan)
- Inderal (propranolol)
- melatonin
- olanzapine
- ondansetron
- oxycodone
- prednisone
- prochlorperazine
- rosuvastatin
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Akynzeo disease interactions
There are 6 disease interactions with Akynzeo (netupitant / palonosetron) which include:
- severe hepatic impairment
- severe renal impairment
- liver impairment
- renal impairment
- end stage renal disease
- hepatic impairment
Report options
QR code containing a link to this page
More about Akynzeo (netupitant / palonosetron)
- Akynzeo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antiemetics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
